Kristen K. Buck - 10 Jan 2022 Form 4 Insider Report for CALADRIUS BIOSCIENCES, INC. (LSTA)

Role: EVP, R&D and CMO
Signature: Kristen K. Buck, by Todd Girolamo, Esq., Attorney-in-Fact
Issuer symbol: LSTA
Transactions as of: 10 Jan 2022
Net transactions value: -$7,055
Form type: 4
Filing time: 12 Jan 2022, 15:18:50 UTC
Previous filing: 03 Sep 2021
Next filing: 02 Sep 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LSTA	Common Stock	Award	$0	+64,500	+25%	$0.000000	326,897	10 Jan 2022	Direct	F1, F2
transaction	LSTA	Common Stock	Tax liability	$7,055	-7,694	-2.4%	$0.9170	319,203	10 Jan 2022	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LSTA	Stock Option (Right to Buy)	Award	$0	+32,500		$0.000000	32,500	10 Jan 2022	Common Stock	32,500	$0.9170	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents 64,500 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.
F2	Includes 257,750 unvested restricted stock.
F3	Shares withheld as payment of a tax liability on vesting of restricted stock.
F4	One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.